Medicated Skin Care in Australia
Euromonitor International's Medicated Skin Care in Australia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 35 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN AUSTRALIA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 4 Medicated Skin Care Company Shares by Value 2004-2008
Table 5 Medicated Skin Care Brand Shares by Value 2005-2008
Table 6 Acne Treatments Brand Shares by Value 2005-2008
Table 7 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 8 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 9 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - AUSTRALIA
EGO PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Ego Pharmaceuticals Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 Ego Pharmaceuticals Pty Ltd: Competitive Position 2008
HERRON PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Herron Pharmaceuticals Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Herron Pharmaceuticals Pty Ltd: Competitive Position 2008
INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 6 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2008
PHARMACARE LABORATORIES PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Pharmacare Laboratories Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Pharmacare Laboratories Pty Ltd: Competitive Position 2008
SYMBION HEALTH LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Symbion Health Ltd: Key Facts
Summary 11 Symbion Health Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 12 Symbion Health Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 13 Symbion Health Ltd: Competitive Position 2008
OTC HEALTHCARE IN AUSTRALIA
EXECUTIVE SUMMARY
OTC healthcare continues to grow steadily
Symbion Health Ltd undergoes multiple acquisitions
Symbion Health Ltd retains lead in OTC healthcare
Retail pressure heat up as grocery retailers continue to strengthen
Moderate growth expected over forecast period
KEY TRENDS AND DEVELOPMENTS
Convenience featuring highly in both product development and distribution
Preference for branded products over generics and private label
Child-specific products experience growth
Negative publicity associated with side effects of OTC healthcare
Rising retail pressures for chemists/pharmacies
MARKET INDICATORS
Table 10 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 11 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 12 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 13 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 14 OTC Healthcare Company Shares by Value 2004-2008
Table 15 OTC Healthcare Brand Shares by Value 2005-2008
Table 16 Penetration of Private Label by Sector 2003-2008
Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 18 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 19 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 14 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 15 Research Sources